Osimertinib then chemotherapy in EGFR-mutated lung cancer with osimertinib third-line rechallenge (OCELOT). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Breadner, Daniel Adam
  • Vincent, Mark David
  • Liu, Geoffrey
  • Rothenstein, Jeffrey
  • Menjak, Ines B
  • Cheema, Parneet Kaur
  • Juergens, Rosalyn
  • Mithoowani, Hamid
  • Bains, Puneet
  • Wang, Ying
  • Wheatley-Price, Paul

publication date

  • June 1, 2023